Wordt geladen...
Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
Cross-reactive immunological material (CRIM) status is an important prognostic factor in patients with infantile Pompe disease (IPD) being treated with enzyme replacement therapy. Western blot analysis of cultured skin fibroblast lysates has been the gold standard for determining CRIM status. Here,...
Bewaard in:
| Gepubliceerd in: | Mol Genet Metab Rep |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674832/ https://ncbi.nlm.nih.gov/pubmed/26693141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgmr.2015.10.012 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|